Research

Brain-Computer Interfaces: Medical Applications, Cognitive Enhancement, and Consent

Medical BCIs demonstrably restore meaningful function in severely paralyzed patients, but the technology is rapidly moving toward cognitive enhancement in healthy users, where expert consensus collapses entirely: Western market-oriented analysts defend individual enhancement rights while most Asian, Middle Eastern, and Global South jurisdictions have enacted explicit bans, and no long-term safety data beyond a few years exists for any invasive system. The consent debate is the briefing's sharpest fault line — whether robust individual consent frameworks suffice, or whether consent becomes structural coercion when employment or care access depends on compliance, a tension that remains unresolved even within the BCI research community, which simultaneously endorses participant data access and restrictions on data sale. Critical gaps include near-total absence of equity outcome data, the underreported speed at which non-invasive BCIs are closing the performance gap with invasive systems, and the fact that modern decoders increasingly capture unintended background mental activity — a privacy risk that current device-category regulations are structurally blind to.